ArticleNature communications2025
Multi-omic relay velocity modeling uncovers dynamic chromatin-transcription regulation across cell states.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Quantitative coupling of clonal CNV evolution and spatially restricted malignant states identifies MFGE8 as a candidate late-state-associated target in breast cancer.Journal of translational medicine · 2026Article
- Multi-omic relay velocity modeling uncovers dynamic chromatin-transcription regulation across cell states.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Cell fate transitions emerge from dynamic gene expression programs, yet existing RNA velocity models primarily rely on RNA abundance and globally inferred latent time, limiting their ability to capture local regulatory dynamics. To address these limitations, we introduce MoFlow, a deep neural network that integrates multi-omic data within a relay velocity framework. Unlike previous approaches, MoFlow flexibly infers velocity parameters at single-cell resolution without pre-assigned latent time, enabling a comprehensive and locally adaptive estimation of gene expression kinetics. Applied to single cell multi-omic datasets from brain, skin, and blood cells, MoFlow distinguished chromatin-dependent and independent transcriptional regulation, validated transcription repression models, and identified asynchronous gene repression in neural progenitors. It also uncovered transcriptional activation of DNA damage response genes in radial glia with distinct subnuclear localization. By resolving fine-grained regulatory programs, MoFlow advances the interpretability and precision of RNA velocity analysis beyond the limits of existing models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.